Analyst Update: GameStop, State Street, Portola Pharma

Analysts adjusted their ratings and price targets on GameStop Corp. (NYSE:GME), State Street Corp (NYSE:STT), and Portola Pharmaceuticals Inc (NASDAQ:PTLA)

Mar 28, 2016 at 3:07 PM
facebook X logo linkedin


Analysts are weighing in on video game retailer GameStop Corp. (NYSE:GME), investment firm State Street Corp (NYSE:STT), and drugmaker Portola Pharmaceuticals Inc (NASDAQ:PTLA). Here's a quick roundup of today's brokerage notes on GME, STT, and PTLA.

  • After falling to as low as $28.40 out of the gate, GME has bounced back to gain 0.2% at $30.32 -- though the stock is stalling out at its 20-day moving average. Late Thursday, GME said fourth-quarter profit beat expectations, yet current-quarter and full-year guidance disappointed. Wedbush has since lowered its price target to $36 from $38, while Benchmark trimmed its target to $26.33 from $27.36. Most of Wall Street is skeptical of GameStop Corp. Eight of the 13 brokerages that cover GME call it a "hold" or "strong sell," while over 38% of the stock's float is sold short. 
  • STT is down 0.5% at $58.48, following a downgrade to "underperform" from "market perform" at KBW. The stock is now 11.9% lower in 2016, and option traders have taken a bearish stance amid in recent weeks. For example, during the past 10 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), State Street Corp has accumulated a call/put volume ratio of 5.58, which tops 70% of similar readings from the past year
  • As expected, negative analyst attention is putting pressure on PTLA. The stock is down 6.6% at $18.94, after Goldman Sachs cut its opinion to "neutral" from "buy," slashed its price target to $30 from $65, and removed the stock from its "America's Buy" list. The shares have dropped over 63% year-to-date, earlier touching a two-year low of $18.20. However, Portola Pharmaceuticals Inc's recent sell-off has left it in oversold territory, with the stock's 14-day Relative Strength Index (RSI) coming in at 26, meaning a short-term bounce is theoretically a possibility. 
For other stocks in analysts' crosshairs, read Analyst Upgrades: Finish Line Inc, Medivation Inc, and McDonald's Corporation and Analyst Downgrades: QUALCOMM, Inc., Atwood Oceanics, Inc., and Transocean LTD.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI